Search research articles
Contact Us
Filters
Showing results (21-30 of 55) with videos related to
Page
of 6
Sort By:
Current Alzheimer Research
|
October 3, 2007
A novel immunotherapy for Alzheimer's disease: antibodies against the beta-secretase cleavage site of APP
Michal Arbel, Beka Solomon
Proceedings of the National Academy of Sciences of the United States of America
|
April 18, 2002
Filamentous phage as vector-mediated antibody delivery to the brain
Dan Frenkel, Beka Solomon
Neuro-Degenerative Diseases
|
March 13, 2010
Filamentous phages reduce alpha-synuclein oligomerization in the membrane fraction of SH-SY5Y cells
Hemi Dimant, Beka Solomon
Neuropharmacology
|
April 15, 2010
Immunotherapy for Alzheimer's disease
Beka Solomon, Dan Frenkel
American Journal of Alzheimer'S Disease and Other Dementias
|
November 9, 2005
Deglycosylation of anti-beta amyloid antibodies inhibits microglia activation in BV-2 cellular model
Sabina Rebe, Beka Solomon
Neuro-Degenerative Diseases
|
August 15, 2013
Inhibition of amyloid precursor protein processing leads to downregulation of apoptotic genes in Alzheimer's disease animal models
Inna Rabinovich-Nikitin, Beka Solomon
Frontiers in Microbiology
|
June 16, 2015
Targeting glioblastoma via intranasal administration of Ff bacteriophages
Eyal Dor-On, Beka Solomon
Neural Regeneration Research
|
December 12, 2024
Amyloid-β is NOT only the most promising target for Alzheimer's disease
Beka Solomon, Milana Voronov-Goldman
Vaccine
|
June 15, 2004
Generation of anti-beta-amyloid antibodies via phage display technology
Dan Frenkel, Mally Dori, Beka Solomon
Neuro-Degenerative Diseases
|
May 31, 2007
Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels
Idan Rakover, Michal Arbel, Beka Solomon
Page
of 6
Search research articles
Search
Showing results (21-30 of 55) with videos related to
Sort By:
Page
of 6
Current Alzheimer Research
|
October 3, 2007
A novel immunotherapy for Alzheimer's disease: antibodies against the beta-secretase cleavage site of APP
Michal Arbel, Beka Solomon
Proceedings of the National Academy of Sciences of the United States of America
|
April 18, 2002
Filamentous phage as vector-mediated antibody delivery to the brain
Dan Frenkel, Beka Solomon
Neuro-Degenerative Diseases
|
March 13, 2010
Filamentous phages reduce alpha-synuclein oligomerization in the membrane fraction of SH-SY5Y cells
Hemi Dimant, Beka Solomon
Neuropharmacology
|
April 15, 2010
Immunotherapy for Alzheimer's disease
Beka Solomon, Dan Frenkel
American Journal of Alzheimer'S Disease and Other Dementias
|
November 9, 2005
Deglycosylation of anti-beta amyloid antibodies inhibits microglia activation in BV-2 cellular model
Sabina Rebe, Beka Solomon
Neuro-Degenerative Diseases
|
August 15, 2013
Inhibition of amyloid precursor protein processing leads to downregulation of apoptotic genes in Alzheimer's disease animal models
Inna Rabinovich-Nikitin, Beka Solomon
Frontiers in Microbiology
|
June 16, 2015
Targeting glioblastoma via intranasal administration of Ff bacteriophages
Eyal Dor-On, Beka Solomon
Neural Regeneration Research
|
December 12, 2024
Amyloid-β is NOT only the most promising target for Alzheimer's disease
Beka Solomon, Milana Voronov-Goldman
Vaccine
|
June 15, 2004
Generation of anti-beta-amyloid antibodies via phage display technology
Dan Frenkel, Mally Dori, Beka Solomon
Neuro-Degenerative Diseases
|
May 31, 2007
Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels
Idan Rakover, Michal Arbel, Beka Solomon
Page
of 6